Korro Bio Inc.

NASDAQ:KRRO   10:05:04 AM EDT
12.70
+0.21 (+1.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)119.26M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.49 Million
Adjusted EPS-$2.57
See more estimates
10-Day MA$12.55
50-Day MA$14.45
200-Day MA$32.01
See more pivots

Korro Bio Inc. Stock, NASDAQ:KRRO

60 First Street, 2nd floor, Cambridge, Massachusetts 02141
United States of America
Phone: +1.617.468.1999
Number of Employees: 104

Description

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.